Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS??? DEFICIT (Tables)

v3.24.3
STOCKHOLDERS’ DEFICIT (Tables)
12 Months Ended
Jun. 30, 2024
Equity [Abstract]  
SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS ACTIVITY

A summary of the Company’s stock option activity during the years ended June 30, 2024 and 2023 is presented below:

 

SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS ACTIVITY

          Weighted  
    Number of     Average  
  Options     Price Per Share  
Outstanding at June 30, 2022     0.059     $             4,533,000  
Issued     -       -  
Exercised     -       -  
Expired     -       -  
Outstanding at June 30, 2023     0.059     $ 4,533,000  
Issued     -       -  
Exercised     -       -  
Expired     -       -  
Outstanding at June 30, 2024     0.059     $ 4,533,000  
                 
Exercisable at June 30, 2024     0.059     $ 4,533,000  
Outstanding and Exercisable:                
                 
Weighted average remaining contractual term     4.87          
Weighted average fair value of options granted during the period   $ -          
Aggregate intrinsic value   $ -          
SCHEDULE OF WARRANT ACTIVITY

The following table summarizes common stock warrant activity for the years ended June 30, 2024 and 2023:

 

SCHEDULE OF WARRANT ACTIVITY

          Weighted  
    Number of     Average  
    Warrants     Price Per Share  
Outstanding at June 30, 2022     105     $                200,270  
Issued     3,305       10  
Exercised     (13 )     52,081  
Forfeited     (1 )     2,000,000  
Expired     -       -  
Outstanding at June 30, 2023     3,396     $ 5,440  
Issued     15,000,000       0.01  
Exercised     -       -  
Forfeited     -       -  
Expired     -       -  
Outstanding at June 30, 2024     15,003,396 *   $ 1.24  
                 
Exercisable at June 30, 2024     15,003,378     $ 1.24  
Outstanding and Exercisable:                
                 
Weighted average remaining contractual term     2.01          
Aggregate intrinsic value   $ -          

 

* The total warrants of 15,003,396 above which are exercisable into common stock consisted of the following:
SCHEDULE OF WARRANT OUTSTANDING AND EXERCISABLE

    Number of Warrants     Exercisable  
Series A warrants     10       10  
Series B warrants     17       17  
Series C warrants     64       46  
Common stock warrants with no class designation     15,003,305       15,003,305  
Total     15,003,396       15,003,378